E. Kelley

E. Kelley

Direttore Tecnico/Scientifico/R&S presso CNS PHARMACEUTICALS, INC.
63 anni
Health Technology
Consumer Services
Consumer Non-Durables

Profilo

E.
Lynne Kelley
is currently Chief Medical Officer at CNS Pharmaceuticals, Inc. since 2026 and Chief Executive & Medical Officer at Signalexis, Inc. Former positions include Chief Medical Officer at Tissium, Inc. from 2024 to 2026; Chief Medical Officer at X4 Pharmaceuticals, Inc. from 2019 to 2020; Chief Medical Officer at Histogenics Corp.
from 2018 to 2019; Vice President-Medical Affairs at Becton, Dickinson & Co. from 2011 to 2016; Medical Director at Kimberly-Clark Corp.
from 2007 to 2010; Medical Director at Boston Scientific Corp.
from 2005 to 2007; Assistant Professor at Yale University from 2003 to 2005; and Chief Medical Officer at Senseonics Holdings, Inc. Education includes undergraduate studies at Boston University and a doctorate from Dartmouth Medical School.

Posizioni attive di E. Kelley

SocietàPosizioneInizio
CNS PHARMACEUTICALS, INC. Direttore Tecnico/Scientifico/R&S 02/03/2026

Precedenti posizioni note di E. Kelley

SocietàPosizioneFine
X4 PHARMACEUTICALS, INC. Direttore Tecnico/Scientifico/R&S 03/04/2020
OCUGEN, INC. Direttore Tecnico/Scientifico/R&S 23/01/2019
BECTON, DICKINSON AND COMPANY Corporate Officer/Principal 01/01/2016
KIMBERLY-CLARK CORPORATION Direttore Tecnico/Scientifico/R&S 01/12/2010
Vedi nel dettaglio l'esperienza di E. Kelley

Formazione di E. Kelley

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

83

Relazioni di 1° grado

10

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private10

Health Technology

Consumer Non-Durables

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Electronic Technology

Health Technology

Health Technology